Status:

UNKNOWN

Microembolisation After Carotid Revascularisation

Lead Sponsor:

University Hospital, Geneva

Conditions:

Carotid Stenosis

Eligibility:

All Genders

18-100 years

Brief Summary

Microembolisation identified on diffusion-weighted magnetic resonance imaging (DW-MRI) is recognized as an important outcome measure for carotid revascularization procedures such as carotid stenting (...

Eligibility Criteria

Inclusion

  • Patients presenting a symptomatic (ipsilateral ischemic stroke, TIA located in the carotid artery territory or retinal ischemia) carotid stenosis between 50% and 99% (according to NASCET and ECST criteria)
  • Patients presenting an asymptomatic carotid stenosis between 60% and 99% (according to NASCET and ECST criteria) Patients who accept the informed consent

Exclusion

  • Important neurological deficit with NIHSS \>7 (or severe aphasia) at time of inclusion
  • Previous known cognitive impairment
  • Pregnancy
  • Presence of contraindication based on ground of multidisciplinary team decision:
  • For surgery:
  • High bifurcation Intracranial extension of the carotid stenosis Patients with tandem lesions High suspicion of severe siphon stenosis Patients with previous irradiation of the cervical region Patients with restenosis after endarterectomy
  • For stenting; Excessive arch vessel or carotid artery tortuosity and in particular presence tortuosity ≤90 degrees in the cervical segment Excessive aortic arch plaque burden Patients older than 70 years Unfavourable anatomic disposition as described above Co-morbidities that may preclude the use of a periprocedural dual antiplatelet regime.
  • For CT-scan Iodine allergy Renal insufficiency
  • For MRI Pacemaker Any other metallic implants Claustrophobia
  • For ultrasound Bad quality ultrasound (patient morphology or equipments

Key Trial Info

Start Date :

March 30 2017

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 30 2019

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT03303430

Start Date

March 30 2017

End Date

March 30 2019

Last Update

October 6 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fisch Loraine

Geneva, Switzerland, 1205